HHS’ Holiday Gift To Industry: Delayed Collection Of Physician Payments Data
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS postpones the deadline for drug makers to begin full implementation of the Sunshine Act until after it issues a final rule on how to collect the data. Current plans are to keep the March 31, 2013, deadline for companies to submit to HHS the data they do collect for 2012.
You may also be interested in...
Looking For Sunshine: Sens. Baucus, Grassley Investigating Financial Ties Between Opioid Manufacturers And Medical Groups
The senators issue letters to Purdue Pharma, Johnson & Johnson and Endo as well as medical groups that have issued recommendations on the prescribing of painkillers, seeking details of payments the manufacturers have made to those groups.
Physician Sunshine Rule Needs Longer Lead Time Before Implementation, PhRMA Says; Scope Challenged By CROs
The Pharmaceutical Research and Manufacturers of America seeks at least a six-month lead time before implementation in comments to CMS. The Association for Clinical Research Organizations takes issue with including payments for “legitimate” research in the rulemaking at all.
Sunshine Proposal Allows Lump Sum Reporting Of Research Payments To Institutions
CMS-proposed rule would allow companies to report a single figure for research payments to institutions and attribute it to the principal investigator(s), although the agency will not include it when computing physicians’ total receipts from industry. The agency wants more details on what payments are for, calling on firms to break them down by category when more than one expense type is included in a single payment.